首页> 外文OA文献 >Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis

【2h】

Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis

机译：肿瘤坏死因子抑制剂的循环与类风湿性关节炎患者对肿瘤坏死因子抑制剂不足反应的不同作用治疗机制的影响：贝叶斯网络荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alberto Migliore; Giuseppe Pompilio; Davide Integlia; Joe Zhuo; Evo Alemao;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis [J] . Alberto Migliore, Giuseppe Pompilio, Davide Integlia, Therapeutic advances in musculoskeletal disease. . 2021,第a期

机译：肿瘤坏死因子抑制剂的循环与类风湿性关节炎患者对不同动作治疗的不同机制，对肿瘤坏死因子抑制剂的反应不足：贝叶斯网络荟萃分析
2. Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy [J] . Wenhui Wei, Keith Knapp, Li Wang, Advances in therapy. . 2017,第8期

机译：治疗持续和肿瘤坏死因子抑制剂循环或切换到新的作用治疗机制的临床结果：现实世界观测研究美国类风湿性关节炎患者与先前肿瘤坏死因子抑制作用治疗
3. Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach. [J] . Hye-Lin Kim, Min-Young Lee, Sun-Young Park, Archives of pharmacal research . 2014,第5期

机译：使用贝叶斯方法对肿瘤坏死因子-α（TNF-α）抑制剂循环治疗与对TNF-α抑制剂反应不足的类风湿关节炎患者循环使用非TNF生物制剂的效果比较。
4. Serum Levels of Tumor Necrosis Factor Alpha in Chronic Schizophrenic Versus Healthy Control and Correlation with Severity of Illness [C] . Rona Hanani Simamora, Bahagia Loebis Public Health International Conference . 2018

机译：慢性精神分裂症患者血清肿瘤坏死因子α的血清水平与健康对照和与疾病严重程度相关
5. Predictors of Infection in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents [D] . Liu, Tasia 2017

机译：类风湿关节炎患者使用抗肿瘤坏死因子药物的感染预测因子
6. Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy [O] . Wenhui Wei, Keith Knapp, Li Wang, -1

机译：肿瘤坏死因子抑制剂循环或转用新的作用机制的治疗持久性和临床结果：美国风湿性关节炎患者接受肿瘤坏死因子抑制剂治疗的现实观察研究
7. Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis [O] . Maria-Cecilia Vieira, Samuel H. Zwillich, Jeroen P. Jansen, 2016

机译：TOFACITINIB与活性类风湿性关节炎患者的生物治疗，对肿瘤坏死因子抑制剂的反应不足：网络元分析的结果

Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis

著录项

引文网络

相似文献

相关主题

期刊订阅